期刊文献+

腧穴热敏灸联合二味拔毒散治疗中老年带状疱疹临床研究 被引量:7

Clinical Study on Treatment of Elderly Herpes Zoster with Moxibustion on Heat-sensitive Acupoints Combined with Erwei Badu Powder
下载PDF
导出
摘要 目的探讨腧穴热敏灸联合二味拔毒散治疗中老年肝经郁热型带状疱疹的疗效和机制。方法将65例肝经郁热型带状疱疹中老年患者随机分为治疗组35例和对照组30例,2组均予口服龙胆泻肝汤、阿昔洛韦片常规治疗,治疗组加用腧穴热敏灸联合二味拔毒散外搽,对照组外搽二味拔毒散,共治疗10 d。治疗前后观察症状、体征积分,检测T淋巴细胞亚群、血清白细胞介素-2(IL-2)水平,评价临床疗效,并随访带状疱疹后遗神经痛(PHN)发生情况。结果治疗组与对照组有效率分别为85.71%(30/35)、66.67%(20/30),治疗组疗效优于对照组(P<0.05),且PHN发生率低于对照组(P<0.01)。2组患者CD4、CD4/CD8、IL-2较治疗前显著升高,CD8显著降低(P<0.05),治疗组各项指标均优于对照组(P<0.05)。结论腧穴热敏灸联合二味拔毒散治疗中老年肝经郁热型带状疱疹疗效优于单用二味拔毒散,尤其在改善神经痛、睡眠及减少PHN发生方面效果显著,其机制可能与升高CD4、CD4/CD8、IL-2,提高机体细胞免疫力有关。 Objective To study the curative effect and mechanism of moxibustion on heat-sensitive acupoints combined with Erwei Badu Powder in the treatment of elderly herpes zoster (HZ) with type of stagnant heat of liver channel. Methods Sixty-five patients with HZ were randomly divided into treatment group (35 cases) and control group (30 cases). Two groups were orally given Longdan Xiegan Decoction and aciclovir conventionally, the treatment group was given moxibustion additionally on heat-sensitive acupoints combined with Erwei Badu Powder, and the control group was only given external application of Erwei Badu Powder for 10 days. The symptom scores, levels of T lymphocyte subsets and serum interleukin-2 (IL-2) were observed before and after treatment, the curative effect was evaluated, and PHN was followed up. Results The effective rate was 85.71%(30/35) in the treatment group and 66.67%(20/30) in the control group. The curative effect of treatment group surpassed the control group (P〈0.05). Incidence of PHN was lower (P〈0.01). The levels of CD4, CD4/CD8, and IL-2 increased and the level of CD8 decreased significantly in two groups compared with those before treatment (P〈0.05). All indexes were better in the treatment group than those in the control group (P〈0.05). Conclusion The curative effect of moxibustion on heat-sensitive acupoints combined with Erwei Badu Powder in treatment of elderly HZ is better than that of Erwei Badu Powder only, particularly in reducing the occurrence of PHN, improving neuralgia and insomnia. The mechanism may be related to increasing levels of CD4, CD4/CD8 and IL-2, and improvement of body’s cell-mediated immunity.
出处 《中国中医药信息杂志》 CAS CSCD 2015年第4期33-36,共4页 Chinese Journal of Information on Traditional Chinese Medicine
基金 江西省中医药科技计划(2010A039)
关键词 腧穴热敏化 灸法 二味拔毒散 带状疱疹 T细胞亚群 白细胞介素-2 临床研究 heat-sensitive acupoint moxibustion Erwei Badu Powder herpes zoster T lymphocyte subsets IL-2 clinical study
  • 相关文献

参考文献7

  • 1戴君来.不同年龄带状疱疹的临床特征及综合治疗研究[J].中国中西医结合皮肤性病学杂志,2003,2(2):83-84. 被引量:18
  • 2余碧娥,方丽,乐嘉豫,朱光斗,秦万章,毛维翰,张定国,郑茂荣,廖万清.伐昔洛韦与阿昔洛韦治疗带状疱疹152例的比较[J].中国新药与临床杂志,1999,18(4):209-212. 被引量:13
  • 3林志淼,杨勇,李若瑜.带状疱疹及后遗神经痛[J].临床皮肤科杂志,2010,39(6):393-395. 被引量:163
  • 4Vossen MTM, Gent MR, Weel JF, et al. Development of virus- specific CD4+ T cells on reexposure to Varicella-Zoster virus[J]. J Infect,2004,190(1):72-82.
  • 5Ku CC, Besser J, Abendroth A, et al. Varicella-Zoster virus pathogenesis and immunobiology:new concepts emerging from investigations with the SCIDhu mouse model[J]. J Virol,2005, 79(5):2651-2658.
  • 6Malavige GN, Jones L, Black AP, et al. Varicella zoster virus glycoprote in E-specific CD4+ cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors[J]. Clin Exp Immunol,2008,152(3):522-531.
  • 7Malavige GN, Jones L, Kamaladasa SD, et al. Viral load, clinical disease severity and cellular immune responses in primary varicella zoster virus infection in Sri Lanka[J]. PLoS One,2008, 3(11):3789-3796.

二级参考文献25

  • 1肖正中,吴海雁.多烯康与阿昔洛韦比较治疗带状疱疹[J].新药与临床,1997,16(1):24-25. 被引量:6
  • 2[4]Freedberg IM, Eisen AZ, WolffK, et al. Fitzpatricks Dermatology in General Medicine [M]. 5th ed. New York: MC Grew-Hill Health Proffecions Division, 1999. 1697-1706.
  • 3[5]Rook A, Wilkinson DS, Ehling FJ, et al. Textbook of Dermatology[M]. 6th ed. Oxford: Blaekwell Scientific Publications, 1998.3278-3286.
  • 4Katz J,Cooper EM,Walther RR,et al.Acute pain in herpes zoster and its impact on health-related quality of life[J].Clin Infect Dis,2004,39(3):342-348.
  • 5Insinga RP,Itzler RF,Pellissier JM,et al.The incidence of herpes roster in a United States administrative database[J].J Gen Intern Med,2005,20(8):748-753.
  • 6Arvin A.Aging,immunity,and the vacicella-roster virus[J].N Engl J Med,2005,352(22):2266-2267.
  • 7Arvin AM.Vaticella-roster virus[J].Clin Microbiol Rev,1996,9(3):361-381.
  • 8Oxman MN,Levin MJ,Johnson GR,et al.A vaccine to prevent herpes roster and postherpetic neuralgia in older adults[J].N Engl J Med,2005,352(22):2271-2284.
  • 9Buchbinder SP,Katz MH,Hessol NA,et al.Herpes roster and human immunodcficieacy virus infection[J].J Infect Dis,1992,166(5):1153-1156.
  • 10Thomas SL,Wheeler JG,Hall AJ.Case-control study of the effect of mechanical trauma on the risk of herpes zoster[J].BMJ,2004,328(7437):439.

共引文献191

同被引文献96

引证文献7

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部